Thursday's earnings session revealed a complex picture across multiple sectors, with retail, FMCG, insurance, and pharma companies delivering varied results. According to reports from CNBC TV18, the day highlighted how headline numbers often mask underlying business trends, with several stocks moving for reasons buried beneath the top-line figures. The session featured a mix of strong performances, disappointments, and surprises that created significant market movements, with investors now tracking how these earnings shape sector-specific bets as the consumer story and pharma narrative influence allocation decisions.
Trent emerged as the most eventful performer, with shares initially climbing 3% after beating expectations across all metrics. As reported by CNBC TV18, the retailer's profit rose 26% to ₹532 crore, but the rally quickly faded as investors focused on like-for-like growth in its fashion portfolio coming in at just low single digits. Britannia delivered healthy double-digit growth in profit and EBITDA from the previous year, yet both metrics came in marginally below Street expectations, with margins easing to 16.8%. LIC presented a contrasting story, with value of new business surging 61.3% and VNB margin expanding by 750 basis points to 22.9%, comfortably ahead of estimates, though total premium equivalent grew just 8.2%.
The healthcare sector maintained its positive trajectory throughout Thursday's session. According to CNBC TV18, Hikal sharply reduced its losses as revenue grew more than 30% and EBITDA climbed 49%, lifting margins to 9% from 6.5% a year earlier. Emcure Pharmaceuticals reported a 42% rise in profit, helped by robust international growth with overseas revenue increasing more than 34% across Europe, Canada and other global markets. Neuland Laboratories continued its strong performance with shares rallying another 10%, with all four analysts maintaining Buy ratings after the company more than doubled quarterly revenue. Among other notable updates, Aurobindo Pharma posted a 25.2% rise in consolidated net profit to ₹1,033 crore, while PB Fintech reported a 91.7% jump to ₹163 crore.
Several stocks experienced significant movements both during and after the earnings announcements. As reported by CNBC TV18, Navin Fluorine climbed another 11% to a record high as investors continued to cheer its earnings and expansion plans announced a day earlier. Cummins India fell 5% as the market digested its ten-quarter-low margin performance and the surprise exit of Managing Director Shveta Arya. Bajaj Electricals stole the spotlight with a near-16% rally after profit surged on sharp margin expansion, marking its strongest intraday gain since February 2021. Blue Star and P&G Health headed in the opposite direction, with Blue Star missing revenue estimates amid an uneven summer season and P&G Health looking past profit growth boosted by a one-off asset sale. Looking ahead, brokerage firm Kotak Institutional Equities expects LIC to report strong 44% YoY VNB growth in Q1 FY27, while Motilal Oswal anticipates Trent to report 22% revenue growth driven by store additions and SSG recovery.
Beyond Thursday's immediate earnings, several companies highlighted their strategic positioning and future plans. According to CNBC TV18, NCC reported a 13% rise in profit while its order book crossed ₹81,200 crore, underscoring continued execution strength. Lloyds Engineering Works more than doubled its profit and entered the new financial year with an order book nearly twice the size it was a year earlier. Looking ahead, Swiggy remained in focus after shares rallied on management's ambition to deliver ₹10,000 crore in adjusted EBITDA by FY31. JK Lakshmi Cement's Arun Shukla told CNBC-TV18 that the company remains on track to expand capacity to 23 million tonnes by FY28. The market context shows Nifty 50 finishing below 24,630 mark on Wednesday, with BSE Sensex gaining 152.05 points to 78,581 and NSE Nifty 50 edging up 9.75 points to 24,624.65.
